Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A

被引:11
|
作者
Wang, Xiaozhu [1 ,2 ]
Huang, Yu [2 ]
Yan, Ming [2 ]
Li, Jiuwei [3 ]
Ding, Changhong [3 ]
Jin, Hong [3 ]
Fang, Fang [3 ]
Yang, Yanling [4 ]
Wu, Baiyan [2 ]
Chen, Dafang [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Basic Med Sci, Dept Med Genet, Hlth Sci Ctr, Beijing 100191, Peoples R China
[3] Capital Med Univ, Beijing Childrens Hosp, Dept Neurol, Beijing 100045, Peoples R China
[4] Peking Univ, Dept Paediat, Hosp 1, Beijing 100034, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
中国国家自然科学基金;
关键词
MUTATIONS; ERCC8; DIAGNOSIS; PROTEIN; CSA;
D O I
10.1038/s41598-017-14034-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There are two genetics complementary groups Cockayne syndrome type A and B (CS-A and CS-B OMIM 216400, 133540), which is a rare autosomal recessive segmental progeroid syndrome. Homozygous or compound heterozygous mutations in the excision repair cross-complementation group 8 gene (ERCC8) result in CS-A, and mutations in ERCC6 result in CS-B. Homozygous ERCC6/ERCC8 mutations also result in UV-sensitive syndrome. In this study, twenty-one Han Chinese patients with CS were investigated to identify mutations in ERCC8/ERCC6, of which thirteen cases with CS-A were identified with the mutations of ERCC8. There are five types mutations of ERCC8 in our study, such as exon 4 rearrangement, c.394_398delTTACA, c.299insA, c.843 + 2T > C, and c.2T > A. An estimated frequency of exon 4 rearrangement accounts for 69.23% and c.394_398delTTACA accounts for 11.53% in our cohort. Haplotype analysis revealed that the exon 4 rearrangement and c.394_398delTTACA mutations originated from a common founder in the Chinese population respectively. With the identification of three novel ERCC8 mutations, this study expanded the molecular spectrum of known ERCC8 defects, and furthermore, suggests that the exon 4 rearrangement and c.394_398delTTACA mutations may be a common underlying cause of CS-A in the Chinese population, which is different from that in other populations.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer
    Kang, Sokbom
    Ju, Woong
    Kim, Jae Weon
    Park, Noh-Hyun
    Song, Yong-Sang
    Kim, Seung Cheol
    Park, Sang-Yoon
    Kang, Soon-Beom
    Lee, Hyo-Pyo
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2006, 38 (03): : 320 - 324
  • [32] Prognostic and Predictive Role of Excision Repair Cross-complementation Group 1 and Thymidylate Synthase in Colorectal Carcinoma Patients Received FOLFOX Chemotherapy: An Immunohistochemical Study
    Badary, Dalia M.
    Elkabsh, Mai M.
    Mady, Hussam H.
    Gabr, Adel
    Kroosh, Sana S.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (10) : 741 - 747
  • [33] Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
    Mountzios, Giannis
    Dimopoulos, Meletios-Athanasios
    Papadimitriou, Christos
    BIOMARKER INSIGHTS, 2008, 3 : 219 - 226
  • [34] Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With Mesothelioma
    Kao, Steven C. H.
    Lee, Kenneth
    Klebe, Sonja
    Henderson, Douglas
    McCaughan, Brian
    Vardy, Janette
    Clarke, Stephen
    van Zandwijk, Nico
    CLINICAL LUNG CANCER, 2013, 14 (02) : 164 - 171
  • [35] Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma
    Scheil-Bertram, Stefanie
    Tylus-Schaaf, Patricia
    du Bois, Andreas
    Harter, Philipp
    Oppitz, Matthias
    Ewald-Riegler, Nina
    Fisseler-Eckhoff, Annette
    GYNECOLOGIC ONCOLOGY, 2010, 119 (02) : 325 - 331
  • [36] Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells
    Jordheim, Lars Petter
    Chettab, Kamel
    Cros-Perrial, Emeline
    Matera, Eva-Laure
    Dumontet, Charles
    PHARMACOLOGY, 2018, 102 (3-4) : 161 - 168
  • [37] Expression of Excision Repair Cross-Complementation Group 1, Breast Cancer Susceptibility 1, and β III-Tubulin in Thymic Epithelial Tumors
    Kaira, Kyoichi
    Serizawa, Masakuni
    Koh, Yasuhiro
    Miura, Satoru
    Kaira, Rieko
    Abe, Masato
    Nakagawa, Kazuo
    Ohde, Yasuhisa
    Okumura, Takehiro
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Kondo, Haruhiko
    Nakajima, Takashi
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : 606 - 613
  • [38] Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer
    Dorff, Tanya B.
    Schuckman, Anne K.
    Schwartz, Rachel
    Rashad, Sadaf
    Bulbul, Ajaz
    Cai, Jie
    Pinski, Jacek
    Ma, Yanling
    Danenberg, Kathleen
    Skinner, Eila
    Quinn, David I.
    CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 450 - 456
  • [39] Expression of excision repair cross-complementation group 1 in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy
    Shen, Chuan
    Chen, Lingling
    Fu, Jiangtao
    Lin, Hongbin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 72 - 75
  • [40] CLINICOPATHOLOGIC SIGNIFICANCE OF EXCISION REPAIR CROSS-COMPLEMENTATION 1 EXPRESSION IN PATIENTS TREATED WITH BREAST-CONSERVING SURGERY AND RADIATION THERAPY
    Goyal, Sharad
    Parikh, Rahul R.
    Green, Camille
    Schiff, Devora
    Moran, Meena S.
    Yang, Qifeng
    Haffty, Bruce G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 679 - 684